Voyager Therapeutics price target lowered to $12 from $14 at Wells Fargo
Wells Fargo lowered the firm’s price target on Voyager Therapeutics (VYGR) to $12 from $14 and keeps an Overweight rating on the shares. With ...
Voyager Therapeutics (NASDAQ:VYGR) Receives “Outperform” Rating from Wedbush
Wedbush reiterated their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report ...
Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now
We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...
Voyager Therapeutics stock hits 52-week low at $4.12
Voyager Therapeutics Inc . (NASDAQ:VYGR) stock has reached a 52-week low, touching down at $4.12. According to InvestingPro analysis, the stock's RSI indicates oversold territory, while the company ...
Voyager Therapeutics CEO Alfred Sandrock sells $74,065 in stock
In a recent transaction, Alfred Sandrock, President and CEO of Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotech company with a market capitalization of $240 million and strong financial health ...